Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

SVP, Clinical & MD Affair

VP Regulatory

VP, Human Resources

Chief Commercial Officer

SVP, General Counsel

VP, Quality

President & CEO

VP, Chief Accounting Officer

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent and graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-20	Premium	sold	Premium	Premium	Premium	SVP, Clinical & MD Affair
2024-03-15	Premium	sold	Premium	Premium	Premium	VP Regulatory
2024-03-14	Premium	sold	Premium	Premium	Premium	VP Regulatory
2024-03-12	Premium	sold	Premium	Premium	Premium	VP, Human Resources
2024-03-05	Premium	sold	Premium	Premium	Premium	SVP, Clinical & MD Affair
2024-03-05	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2024-03-05	Premium	sold	Premium	Premium	Premium	SVP, General Counsel
2024-03-05	Premium	sold	Premium	Premium	Premium	VP Regulatory
2024-03-05	Premium	sold	Premium	Premium	Premium	VP, Quality
2024-03-05	Premium	sold	Premium	Premium	Premium	President & CEO
2024-03-05	Premium	sold	Premium	Premium	Premium	VP, Human Resources
2024-03-05	Premium	sold	Premium	Premium	Premium	VP, Chief Accounting Officer
2024-03-01	Premium	acquired	Premium	Premium	Premium	VP Regulatory
2024-03-01	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2024-03-01	Premium	acquired	Premium	Premium	Premium	VP, Quality
2024-03-01	Premium	acquired	Premium	Premium	Premium	SVP, General Counsel
2024-03-01	Premium	sold	Premium	Premium	Premium	SVP, Clinical & MD Affair
2024-03-01	Premium	acquired	Premium	Premium	Premium	President & CEO

AORT - Artivion, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for AORT